Alkem Labs: How This Pharma Stock Plans to Sustain Growth Despite Margin Pressures
India, June 7 -- The article outlines how this pharma company will maintain its growth, which is one of the oldest industrial houses in India, specializing in the research, manufacturing, and global marketing of generic formulations and Active Pharmaceutical Ingredients
With a market capitalization of Rs 62,842 crore, Alkem Laboratories Ltd's share closed at Rs 5,256 per share, down 0.39 percent from its previous day's close. The share of the company gave a return of 8 percent over the last years.
Nomura on Alkem Labs
Nomura maintained a Buy rating on Alkem Labs with a target price of Rs 6,890, indicating an upside potential of 31 percent. The brokerage cited strong margin performance and viewed the quarter's exceptional losses as one-t...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.